Tamarack Advisers, LP Biocryst Pharmaceuticals Inc Put Options Transaction History
Tamarack Advisers, LP
- $2.12 Billion
- Q4 2023
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BCRX
# of Institutions
284Shares Held
173MCall Options Held
612KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA21.9MShares$192 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$175 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$104 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$79.8 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$77.7 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.63B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...